President Trump signed an EO last week that directs federal agencies to reschedule cannabis. The move will benefit US MSOs, including Cresco Labs, because they will be free of the 280e tax burden.

CHICAGO, December 18, 2025--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie ...

MediPharm Labs ( (TSE:LABS)) has issued an update. MediPharm Labs is positioning itself to capitalize on the U.S. decision to reclassify cannabis from Schedule I to Schedule III, a move that ...

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision ...

MediPharm Labs (MEDIF) welcomes U.S. President Donald Trump’s executive order to expedite the reclassification of cannabis under the U.S. Controlled Substances Act from Schedule I to Schedule III.

The latest announcement is out from Cresco Labs ( (TSE:CL)). Cresco Labs has welcomed the U.S. federal government’s decision to move cannabis from Schedule I to Schedule III, calling it the most ...

Political committees, consultants, and lobbyists linked to President Donald Trump made out with millions of dollars in ...

Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana. Reports first emerged last week that the ...

A mysterious metal shard captured the imagination of the American public, because it was supposedly from a 1947 UFO that crashed on Earth. The sample seemed to have an unprecedented material structure ...

“The Secret Agent,” Brazil’s official film entry for the upcoming 98th Academy Awards, is a historical political thriller ...